Leveraging Single-Cell Sequencing for Chimeric Antigen Receptor T Cell Therapies
{{output}}
Chimeric antigen receptor (CAR)-T cell therapies against cancer continue to make inroads in the clinic. However, progress is still hindered by subpar efficacy against many tumors. Gaining a better understanding of CAR-induced T cell activation would help ident... ...
